Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: Two years of follow-up

Scandinavian Journal of Rheumatology, Supplement

Volumn 25, Issue 103, 1996, Pages 91-93

  Sebaldt, R J ^a,b   Adachi, J D ^a   Bensen, W G ^a   Bianchi, F ^a   Cividano, A ^a   Craig, G L ^a   Cranney, A ^a   Kaminska, E ^a   Gordon, M ^a   Steele, M ^a   Goldsmith, C ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

Bone mineral density; Cohort study; Corticosteroids; Database; Etidronate; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; ETIDRONIC ACID;

ADULT; ASTHMA; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTICLE; COHORT ANALYSIS; DRUG ADMINISTRATION; DRUG EFFECT; INFORMATION SYSTEM; MIDDLE AGED; RHEUMATIC DISEASE; TIME;

ADRENAL CORTEX HORMONES; BONE DENSITY; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; ETIDRONIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFORMATION SYSTEMS; MALE; MIDDLE AGED; OSTEOPOROSIS; RHEUMATIC DISEASES; TIME FACTORS;

EID: 0029938125     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609103760     Document Type: Conference Paper

References (5)

1. Adachi JD, Steele M, Gordon M, et al. Nasal salmon calcitonin in the prevention of corticosteroid-induced osteoporosis (abstr). J Bone Miner Res 1992; 7:S193.
2. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992; 7:1063-9.
3. Reid IR, King AR, Alexander CJ, Ibbertson HK. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988; 1:143-6.
4. Watts NB, Harris ST, Genant HK et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323:73-9.
5. Mulder H, Snelder HAA. Effect of cyclical etidronate regimen on prophylaxis of bone loss of glucocorticoid (Prednisone) therapy in postmenopausal women (abstr). J Bone Miner Res 1992; 7:S331.